(+)-(5aR,10bS)-5a,10b-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]氯化恶唑鎓一水合物
(+)-(5aR,10bS)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Chloride Monohydrate
| 中文别名 | BODE 催化剂 2、(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲苯基)-4H,6H-茚并[2,1-B]-1,2,4-三唑并[4,3-D]-1,4-嗪氯化物、(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B]-1,2,4-三唑并[4,3-D]-1,4-噁嗪鎓氯化物、(+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一、(+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑并[4,3-D][1,4]恶嗪鎓氯化物、(+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物、(+)-(5A<I>R</I>,10B<I>S</I>)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4<I>H</I>,6<I>H</I>-茚并[2,1-<I>B</I>][1,2,4]三唑[4,3-<I>D</I>][1,4]氯化恶唑鎓一水合物、(+)-(5AR,10BS)-5A,10B-DIHYDRO-2-(2,4,6-TRIMETHYLPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIAZOLO[4,3-D][1,4]OXAZINIUM CHLORIDE MONOHYDRATE (+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物 |
| CAS号 | 903571-02-8 |
| 分子式 | C21H22ClN3O |
| 分子量 | 367.9 |
| 产品分类 | 普通化学品 |
| 纯度 | 98%,LC |
| 包装规格 | 1g,25mg,100mg,250mg,500g,25kg |
产品详情

相关关键词: BODE 催化剂 2,(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲苯基)-4H,6H-茚并[2,1-B]-1,2,4-三唑并[4,3-D]-1,4-嗪氯化物,(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B]-1,2,4-三唑并[4,3-D]-1,4-噁嗪鎓氯化物,(+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一,(+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑并[4,3-D][1,4]恶嗪鎓氯化物,(+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物,(+)-(5A<I>R</I>,10B<I>S</I>)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4<I>H</I>,6<I>H</I>-茚并[2,1-<I>B</I>][1,2,4]三唑[4,3-<I>D</I>][1,4]氯化恶唑鎓一水合物,(+)-(5AR,10BS)-5A,10B-DIHYDRO-2-(2,4,6-TRIMETHYLPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIAZOLO[4,3-D][1,4]OXAZINIUM CHLORIDE MONOHYDRATE (+)-(5AR,10BS)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物